Dental anxiety in adolescents with a history of childhood dental sedation.
The purpose of this study was to determine whether adolescents with a history of childhood dental treatment using sedation had a higher level of self-reported dental anxiety than adolescents without such a history. A group of 287 adolescents were identified who had received dental treatment using an identical sedation regime during childhood (mean age 5.05 +/- 0.16 years). A cover letter and a modified Dental Anxiety Scale (DAS) were mailed to the parents of all subjects. Sixty-one subjects (n = 61, 21 males, 40 females, mean age = 14.79 +/- 0.16 years) (+/- SE) completed and returned the form. Age matched control subjects (n = 38, 18 females, 20 males, mean age = 14.36 +/- 0.06 years) who had no history of sedation or general anesthesia for dental or medical procedures also completed the DAS. Using the Mann-Whitney U test, the DAS score for test subjects (13.49 +/- 0.76) was found to be significantly higher (p < 0.05) than the DAS score for control subjects (10.84 +/- 0.69).
Koroluk
L D
LD
Department of Pediatric Dentistry and Orthodontics, School of Dentistry, University of North Carolina at Chapel Hill, USA.
D000759:Adjuvants, Anesthesia / Q000627:therapeutic use; D000293:Adolescent; D000294:Adolescent Behavior; D000367:Age Factors; D000766:Anesthesia, Dental / Q000523:psychology; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D002746:Chlorpromazine / Q000627:therapeutic use; D016854:Dental Anxiety / Q000209:etiology* / Q000523:psychology; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D008297:Male; D008614:Meperidine / Q000627:therapeutic use; D011229:Preanesthetic Medication / Q000523:psychology; D011398:Promethazine / Q000627:therapeutic use; D012647:Self-Assessment
D000759:Adjuvants, Anesthesia; D006993:Hypnotics and Sedatives; D008614:Meperidine; D011398:Promethazine; D002746:Chlorpromazine